Found 44 matching trials
Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate PHASE2 This study is being done with people with HIV infection who have low levels...
Show More Location
Alabama Therapeutics CRS (5801)
Learn More & Join Trial
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067) PHASE3 This is a 12-Week clinical trial in patients with Primary hypercholesterole...
Show More Location
Multiple Locations
Learn More & Join Trial
Effects of Niacin Therapy on Lipoprotein Composition and Function NA Background:
\- Niacin is a vitamin in many foods, including meats, fish, f...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118) PHASE3 This study is being done to find out if tablets containing extended release...
Show More Location
Multiple Locations
Learn More & Join Trial
The Impact of Tredaptive on Flow-Mediated Dilation in Cardiac Patients PHASE4 Laropiprant (LRP; Merck \& Co., Inc, Whitehouse Station, NJ, USA) is a pote...
Show More Location
Leviev Heart Center, Sheba Medical Center
Learn More & Join Trial
Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents PHASE2 This phase II, open-label research study was conducted in 129 healthy volun...
Show More Location
University of Pennsylvania
Learn More & Join Trial
Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED) PHASE3 This is a 12-week clinical trial in lipid clinic patients for whom niacin t...
Show More Location
Multiple Locations
Learn More & Join Trial
Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED) PHASE2 This study will examine the effect of statin and niacin therapy on carotid ...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE PHASE3 The primary aim is to assess the effects of raising HDL cholesterol (the go...
Show More Location
Clinical Trial Service Unit, University of Oxford
Learn More & Join Trial
Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer PHASE2 RATIONALE: Sorafenib may stop the growth of tumor cells by blocking blood f...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial